The effects of dopamine agonests on CBF (133XE dynamic spect) and negative symptoms in schizophrenia

D.G. Daniel(St. Elizabeths Hospital), T E Goldberg, Joel E. Kleinman(Johns Hopkins University), Richard Coppola(United States Department of Health and Human Services), Karen F. Berman(National Institute of Mental Health), D.R. Weinberger(St. Elizabeths Hospital), Llewellyn B. Bigelow, Douglas W. Jones(University of Massachusetts Chan Medical School), J.R. Zigun(National Institutes of Health), Nancy A. Breslin
Schizophrenia Research
January 1, 1990
Cited by 5


Related Papers